DOI: 10.3897/bgcardio.31.e167638

Authors: D. Topalov

Abstract: The subclinical atrial fi brillation (SCAF) in patients with cardiac implanted electronic devices (CIED) is a critical area of research in cardiology. It represents episodes of atrial fi brillation (AF) that occur in patients without any noticeable symptoms, registered by electronic devices for prolonged rhythm monitoring. Because of that, early diagnosis has proven to be diffi cult in the absence of advanced monitoring tools, such as smart electronic devices or implantable cardiac hardware. CIED, such as permanent pacemakers (PPM), implantable cardioverter defi brillators (ICD), resynchronization devices (CRT) and Loop Recorders (IRL) are fundamental in the detection of such episodes and provide continuous monitoring of the cardiac electrical activity. The early detections of SCAF provide the ability to initiate early prophylactic or therapeutic measurements that will help reduce not only the burden of disease, but also to reduce morbidity and mortality. The widespread use of CIED`s and wearable devices has led to the detection of subclinical AF in a signifi cant portion of the population. Thus, this detection may often help reduce the incidents of thromboembolism by initiating anticoagulation therapy. However, it is still unknown at what point and in which population long-term anticoagulation is benefi cial, having also in consideration the hemorrhagic risk. This review aims to explore the existing data and to identify the current gaps in knowledge.

HTML

PDF

DOI: 10.3897/bgcardio.31.e153312

Authors: Zh. Kolev, V. Valkov, A. Angelov

Abstract: Transcatheter aortic valve implantation is gradually becoming the main method of treatment for high-grade aortic valve stenosis. As the indications for the procedure gradually expand and the incidence of severe aortic valve stenosis increases, given the aging population, the number of procedures performed will grow. Despite the minimally invasive nature of the procedure, it remains associated with some inherent complications. One of them is the conduction disturbances after transcatheter aortic valve implantation. Knowledge of the incidence, evolution over time and clinical signifi cance of this type of complications of the procedure is of great importance for the proper management of patients. In recent years, various clinical trials have investigated complications of the conduction system after transcatheter aortic valve implantation. The purpose of this literature review is to discuss established data from the literature related to the incidence, evolution, and clinical signifi cance, primarily of new-onset complete left bundle branch block or permanent pacemaker implantation after transcatheter aortic valve implantation.

HTML

PDF

DOI: 10.3897/bgcardio.31.e165330

Authors: V. Gitsov, K. Gospodinov, S. Tisheva, K. Razlozhka

Abstract: Cardio-oncology is a new fi eld in medicine, uniting the two clinical disciplines of cardiology and oncology. With the improvement of anticancer therapies, patient survival has increased, creating conditions for the development of cardiovascular diseases, including rhythm and conduction disorders. Furthermore, the medications used for cancer treatment are themselves associated with cardiovascular system damage. The aim of this publication is to provide a brief overview of rhythm and conduction disorders resulting from treatment with anticancer drugs, to present the medications with the highest cardiotoxicity risk, and the mechanisms and factors that predispose to it.

HTML

PDF

DOI: 10.3897/bgcardio.31.e152746

Authors: T. Shalganov, M. Stoyanov, K. Dzhinsov

Abstract: This study presents data from the national electronic registry BG-EPHY on electrophysiologic (EP) studies and catheter ablations in 2024. Material and methods: Full one-year sample of the BG-EPHY registry was analysed retrospectively. Sex and age distribution of the patients, number of ablations, use of electroanatomic mapping (EAM), ablation energy source, distribution of different types of arrhythmias, acute procedural success, complications, recurrences and redo procedures are presented. Results: In 2024 ten EP centers performed 2624 ablations in 1714 men (65.3%) and 910 women, incl. 16 ablations in pediatric patients (0.61%). EAM was used in 1506 procedures (57.4%), irrigated-tip catheter – in 1535 (58.5%), cryocatheter – in 507 (19.3%), and intracardiac echocardiography – in 203 (7.7%). The most frequently performed primary ablation was pulmonary vein isolation (51.9%), followed by ablation for typical atrial flutter (15.1%) and AV nodal reentrant tachycardia (13.5%). The acute success was over 99%, while intraprocedural complications were less than 1.5%. Redo procedures for recurrence of the index arrhythmia were done in 190 patients (7.24%), with atrial fibrillation and atrial flutters accounting for the largest numbers (n = 147). Conclusion: The national registry of electrophysiology collects systematically and continuously data on all ablations of cardiac arrhythmias performed in the country. In 2024, the number of ablations increased compared to 2023, but at a slower pace. Distribution of EP procedure types was similar to previous years. Acute success was very high, while intraprocedural complications were rare.

HTML

PDF

DOI: 10.3897/bgcardio.31.e146569

Authors: S. Kitov, L. Kitova

Abstract: The etiopathogenetic mechanisms of metabolic syndrome that affect cardiac electrophysiology and lead to myocardial remodelling are numerous. Cardiomyocyte changes induced by metabolic and proinflammatory factors impair repolarization, exacerbate the heterogeneity of the transmural dispersion of repolarization, and prolong the Tpeak-end interval. Tpeak-Tend interval has been described as a marker of arrhythmogenicity that is more sensitive than the standard QT interval. Multiple pathological conditions and their effect on myocardial repolarisation have been studied – coronary artery disease, sleep apnea, arterial hypertension, Brugada syndrome and other channelopathies, systemic sclerosis, endocrinological diseases such as hypothyroidism, diabetes mellitus, acromegaly, hypertrophic cardiomyopathy, sudden cardiac death, familial hypercholesterolemia, etc. Currently, the most widely accepted theory of the mechanism of formation of Tp-e the interval and its dynamics are transmural myocardial heterogeneity/dispersion repolarisation. For the clinician, this is an additional tool for assessment of arrhythmogenicity through easy and accessible electrocardiographic markers in daily clinical practice. There is very little literature data on the clinical application of electrocardiographic markers (Tp-e interval, Tp-e/QT ratio) for proarrhythmogenicity in patients with metabolic syndrome. Despite progress in the development of new cardiovascular diagnostic methods, electrocardiographic markers can help in daily clinical practice to add important prognostic information about proarrhythmogenicity.

HTML

PDF

DOI: 10.3897/bgcardio.30.e137573

Authors: T. Shalganov, I. Baltov, R. Ralchovski, I. Dostov, M. Stoyanov

Abstract: Inadvertent vagal denervation has been reported as an adjunctive effect during pulmonary vein isolation (PVI) for atrial fibrillation (AF). However, it is not known how frequent and durable this effect is during thermal ablation. Material and methods: This is a retrospective study of consecutive patients with AF and first PVI in sinus rhythm using radiofrequency or cryogenic energy. We studied the incidence of non-targeted and non-transient heart rate (HR) acceleration, induction and abolition of vagal reflex (VR), as well as the durability of the HR increase at the end of the first month. Results: PVI was carried out in 102 patients (cryo, n = 46). Overall, 60 patients (58.8%) had inadvertent neuromodulation, presented by VR induction and abolition (n = 18, 17.6%) and predominantly by HR increase (n = 50, 49%). In patients with vs those without HR acceleration the mean HR increase at the end of the procedure was 14.2 ± 5.64 bpm vs. -2.63 ± 5.43 bpm, and at the next day – 10.6 ± 7.53 bpm vs. 3.68 ± 7.75 bpm (p < 0.001 for all). The mean HR at 1 month was 74.2 ± 9.91 bpm vs. 68.9 ± 12 bpm (p = 0.048). Patients with a durable HR increase were younger (median age 61 vs. 65.5 years, p = 0.016) and less frequently had heart failure with reduced ejection fraction (1% vs. 6.9%, p = 0.031). Conclusion: Inadvertent neu-romodulation occurs in more than half of the patients with radiofrequency or cryo PVI for AF. It is mostly represented by a HR increase and persists for up to at least one month post-procedurally.

HTML

PDF

DOI: 10.3897/bgcardio.30.e127290

Authors: N. Koleva, Y. Yotov, K. Dzhinsov, I. Gruev, M. Gospodinova

Abstract: The 2023 European Society of Cardiology guidelines for the management of cardiomyopathies (CM) provide practical recommendations for diagnosis and treatment. They emphasize on the need for a systematic clinical evaluation beginning with clinical suspicion of CM and using a multiparametric approach that leads to classification of CM into one of five distinct phenotypes. А cardiomyopathy mindset, together with a multidisciplinary approach are crucial. Further investigations, including advanced imaging and genetic testing, are needed to make a phenotype-based etiological diagnosis. Detection of pathogenic genetic variants allows risk stratification of sudden cardiac death, where new recommendations are available regarding primary prevention. Therapeutic options are expanded with the approval of a new class of drugs for the treatment of symptomatic hypertrophic cardiomyopathy with left ventricular outflow tract obstruction. Specific exercise recommendations are given and reproductive issues in patients with CM are addressed. The lack of reimbursement by the National Health Insurance Fund (NHIF) of genetic testing and the severely limited reimbursement of some imaging methods are a significant problem in Bulgaria, which leads to difficulties in implementing the new guidelines.

HTML

PDF

DOI: 10.3897/bgcardio.30.e118587

Authors: Zh. Kolev, D. Topalov, A. Angelov, Zh. Ilieva

Abstract: Drug induced bradycardia is a frequent reason for hospitalization in cardiology clinic. Knowing the causes of this type of bradycardia is important for the proper management of these patients. Pyridostigmine bromide is an indirect parasympathomimetic drug, inhibitor of the cholinesterase enzyme. Pyridostigmine decrease the breakdown of acetylcholine, which is the natural neurotransmitter of the electrical impulses send by the somatic and parasympathetic nervous systems. Despite its relative safety and effectiveness, in rare cases there have been reports of conduction disturbances of the heart. In this clinical case report, we present a patient with atonic bladder treated with pyridostigmine. The patient developed a rare adverse reaction of the drug with an induced second-degree аtrioventricular block 2:1 type. The bradycardia caused pronounced symptoms which forced hospitalization in intensive cardiology clinic.

HTML

PDF

DOI: 10.3897/bgcardio.30.e120728

Authors: T. Shalganov, M. Stoyanov, K. Dzhinsov

Abstract: This study presents data from the national electronic registry BG-EPHY on electrophysiologic (EP) cardiac ablations in 2023. Material and methods. This is a retrospective study of a full one-year sample of the BG-EPHY registry. Sex and age distribution of the patients, number of ablations, use of electroanatomic mapping (EAM), irrigated and cryoablations, distribution of different types of arrhythmias, acute procedural success, and complications are presented. Results. In 2023 nine EP centers performed 2021 ablations in 1309 men (61.8%) and 807 women, incl. 20 ablations in pediatric patients (1%). EAM was used in 941 procedures (46.6%), irrigated-tip catheter – in 1121 (55.5%), cryocatheter – in 420 (20.8%), and intracardiac echocardiography – in 43 (2.1%). The most frequently performed ablation was pulmonary vein isolation (46.4%), followed by ablation for AV nodal reentrant tachycardia (16.3%) and typical atrial flutter (15.2%). The acute success was over 98%, while intraprocedural complications were less than 2%. Conclusion. The national registry of electrophysiology collects systematically and continuously basic data on all ablations of cardiac arrhythmias performed in the country. In 2023, after the end of the COVID-19 pandemic, the number of ablations increased compared to 2022, but at a slightly slower rate. Distribution of EP procedure types was similar to previous years. Acute success was very high, while intraprocedural complications were rare.

HTML

PDF

DOI: 10.3897/bgcardio.29.e113063

Authors: M. Peneva, H. Baychev, I. Baltov, L. Abujamus, Ts. Doychinova, H. Nikolov, V. Baycheva, H. Mateev, E. Trendafilova

Abstract: Takotsubo cardiomyopathy or broken heart syndrome is a stress-induced cardiomyopathy with clinical, laboratory and ECG resemblance to acute coronary syndrome. Major differences stem from transient segmental wall motion abnormalities beyond the territory of a single coronary artery and the lack of obstructive coronary disease during angiography. Overall the condition is considered as a benign one with a favourable outcome, however there are reports of complicated clinical course by cardiogenic shock, apical thrombus, death and arrhythmias. The latter are reported to occur in 13% of the cases with ventricular arrhythmias (ventricular tachycardia, ventricular fi brillation, torsades de pointes) as a leading fi nding and in minor percentage – high-grade AV block. Despite advances in our knowledge and experience there are still no strict guidelines for the management of conduction disorders. We present the case of a 78-year old lady with an apical variant of Takotsubo, complicated by syncope, complete AV block, new left bundle branch block, paroxysmal atrial fi brillation, ventricular tachycardia and implantation of a permanent pacemaker. During the hospitalization she developed acute cardiac failure with echocardiographic evidence of left ventricular systolic dysfunction and an apical thrombus. The presented case demonstrates the complexity of the condition and the necessity of strict follow-up and timely therapy.

HTML

XML

PDF

DOI: 10.3897/bgcardio.29.e114208

Authors: S. Vasilev, S. Ivanova, A. Keltchev

Abstract: Cardiac implantable electronic devices (CIEDs) implantation procedure has a complication rate of 5-6% according to most studies. Lead perforation is a possible and serious adverse event which can present with a spectrum of symptoms from asymptomatic to sudden death. Diagnostic tools in case of suspected lead perforation are X-ray, transthoracic echocardiography, pacemaker interrogation and computed tomography with the last one being the gold standard. Lead extraction could be done endovascularly or surgically. Transvenous removal is a possible option for active fi xation leads, while removal of passive fi xation leads is preferably done surgically, because of the bulky tip of the lead, which could damage the heart chambers and the vessels. In this article, we present a case of a massive ventricular perforation from a passive fi xation lead, further complicated by a cardiac tamponade. Surgical removal was the treatment of choice with subsequent implantation of a permanent dual-chamber pacemaker.

HTML

PDF

DOI: 10.3897/bgcardio.29.e116261

Authors: E. Martinov, D. Boychev, M. Marinov, V. Konstantinova, V. Gelev, V. Traykov

Abstract: Conduction system pacing (CSP) is a pacing technique involving the implantation of permanent pacing leads at different sites along the cardiac conduction system and includes His bundle pacing (HBP) and left bundle branch area pacing (LBBAP). Intracardiac echocardiography (ICE) might facilitate the implantation of the permanent pacing lead in the left bundle branch (LBB) area of the interventricular septum. We report a case of an 83-year-old patient presenting with right bundle branch block (RBBB), left anterior fascicular block (LAFB), and dizzy spells during episodes of 2:1 atrioventricular (AV) block who underwent CSP with ICE guidance at our center. Apart from standard fl uoroscopic guidance and monitoring of intracardiac signals, ICE was also used to monitor lead advancement in the septum during the implantation. The landing zone and penetration depth of the pacing lead through the RV septum, mid-septum, and LBB area septum were easily visualized with ICE. Selective LBBAP demonstrated by the accepted ECG and electrogram criteria was achieved. Automated strain rate protocol with speckle tracking was used to demonstrate preserved left ventricular (LV) synchrony following the implantation. The use of ICE to guide LBBAP implantation can be used to monitor lead penetration in the septum, potentially improving the safety and effi cacy of this promising pacing modality.

HTML

PDF

DOI: 10.3897/bgcardio.29.e116198

Authors: M Szotek, W. Kula, A. Malik, A. Czunko, J. Lelakowski, V. Traykov, P. Matusik

Abstract: We present a case of a 78-year-old patient with persistent atrial fl utter, history of atrial fi brillation and atrioventricular conduction disturbances, including fi rst-degree atrioventricular block (AVB) and paroxysmal complete AVB. Echocardiography revealed mildly reduced left ventricular ejection fraction (LVEF, 44%). The patient had high thromboembolic risk, had previous ischemic stroke, suffered from chronic coronary artery disease treated with hybrid coronary revascularization (minimally invasive direct coronary artery bypass grafting and subsequent percutaneous coronary intervention) as well as left atrial appendage closure. Because of high bleeding risk, double antiplatelet therapy (acetylsalicylic acid and clopidogrel) combined with low dose of low-molecular-weight heparin after cardiac surgery were introduced. Due to persistent atrial fl utter, complete AVB, lack of intraventricular conduction abnormalities, mildly reduced LVEF and expected high right ventricle pacing burden, the patient was referred for dual-chamber pacemaker implantation using conduction system pacing (CSP), preferentially His bundle pacing (HBP). The procedure was performed with good outcome and CSP was utilized via HBP. After reassessment of thromboembolic and bleeding risk, the patient was discharged home on reduced dose of dabigatran. Short-term follow-up showed stable HBP parameters along with no additional symptoms. Despite good short-term outcomes and no complications in studied patient, large randomized controlled trials are needed to verify long-term safety and effi cacy of HBP to optimize clinical care of patients with atrioventricular conduction abnormalities using a personalized approach.

HTML

PDF

DOI: 10.3897/bgcardio.29.e106912

Authors: T. Shalganov, M. Stoyanov

Abstract: A case is presented of a patient with a rare narrow QRS tachycardia with alternating R-R intervals in the presence of dual AV nodal physiology. The tachycardia was successfully treated by catheter ablation. The mechanism of the arrhythmia and the intracardiac and ECG recordings are discussed.

HTML

XML

PDF

DOI: 10.3897/bgcardio.29.e112624

Authors: T. Shalganov, M. Stoyanov, I. Bayraktarova, L. Bardarska

Abstract: Patients with recurrent vasovagal syncope with cardioinhibitory or mixed mechanism, or with symptomatic functional sinus bradycardia or AV block can be treated with cardioneuroablation. Material and methods: A case series of 5 patients is presented – four with recurrent syncope and/or symptomatic sinus bradycardia, and one with paroxysmal atrial fi brillation and recurrent syncope. After a confi rmation of the syncope mechanism with tilt table test, and after positive atropine test, radiofrequency catheter cardioneuroablation was performed (this was adjunctive procedure for the patient with atrial fi brillation who received pulmonary vein isolation). During short-term follow-up none of the patients had syncopal recurrence. Conclusion: Catheter neuromodulation provided very good short-term results and lack of serious complications in this fi rst case series in Bulgaria.

HTML

PDF

DOI: 10.3897/bgcardio.29.e115081

Authors: K. Dzhinsov, E. Georgieva, V. Traykov, L. Bardarska, D. Boychev, T. Balabanski

Abstract: Introduction: Over the last decades the rate and rhythm control options available for patients with atrial fi brillation (AF) have been aimed at improving arrhythmia symptoms and quality of life (QoL). In terms of rhythm control catheter ablation has become a valid treatment option. Since it is an invasive and relatively costly procedure generally performed with the aim of symptom control, obtaining information on the degree to which QoL is affected by the intervention is of great importance. The aim of the present study was to assess the effect of pulmonary vein isolation (PVI) on the QoL of patients with AF and to determine the factors of greatest infl uence on the change in QoL. Material and methods: This was a multicenter prospective cohort study involving patients with atrial fi brillation who underwent radiofrequency PVI. Standardized questionnaires and scores were used to assess QoL before the procedure and at the end of the follow-up period. Results: The study included 131 patients at mean age of 59 ± 9.27 years, 75.6% (n=99) were men. The patients were followed for a mean of 39.7 ± 13.3 months. At the end of the follow-up period, we observed a signifi cant improvement (p < 0.001) in all domains of quality of life compared to baseline. Through multivariate regression analysis, left ventricular ejection fraction (p = 0.047), mitral regurgitation (p < 0.0001), body mass index (p = 0.002) and recurrences within the fi rst 3 months following PVI (p = 0.009) were found to be independent predictors of the change in QoL before and after ablation. Conclusion: Catheter ablation of atrial fi brillation results in improvement of QoL in patients with AF. Left ventricular ejection fraction, functional mitral regurgitation, body mass index and recurrences within the fi rst 3 months following PVI are important predictors of change in QoL after radiofrequency ablation. They are to be considered when choosing therapeutic strategy and defi ning the individual approach to each AF patient.

HTML

PDF

DOI: 10.3897/bgcardio.29.e116391

Authors: V. Traykov, Sv. Iovev, B. Borisov, M. Marinov, V. Velchev, K. Dzhinsov

Abstract: The current study analyses the activity on cardiac pacing in Bulgaria in 2022 based on data derived from a national registry of patients with cardiac implantable electronic devices (CIEDs). Materials and methods. Data from the national registry BG-Pace for 2022 was studied retrospectively. Demographic data, procedure and device type, pacing mode, etiology, symptoms, preimplantation ECG, number of implantations, and centre and operator volumes were analyzed. Results: Four thousand seven hundred seventy devices were implanted by 45 operators in 30 centers. Median age was 76 (IQR 69-82, 14-98) years, and male patients were 2843 (59,6%). The most significant number of implantations were carried out in the age group 70-79 years. The most commonly implanted CIEDs were antibradycardia devices - 578,8/million. Of them, conduction system pacing was used in 111 (2.3%). Implanted cardioverter-defibrillators demonstrated a growth compared to previous periods and reached 31.9/million. Cardiac resynchronization defibrillators implantations also shown a growth to 15.9/million. A considerable increase was found with implantable loop-recorders, which reached 8.8/million. Number of implantations per center was 115.5 (IQR 53-261.,3, 3-546), and 76,5 (IQR 36,8-154,8, 3-364) devices per operator. Dual chamber devices were most commonly implanted with a share of 83.1% in AVB I and II degrees, 72.5% in complete AVB, 82.6% in intraventricular conduction disturbances, and in 66.8% in patients with sick sinus syndrome. Pacing modes allowing for atrial sensing were most frequently implanted – 62.4% of all implantations for conduction disturbances. There was a significant increase in the use of VVI mode with increasing age (P<0.001). Conclusion: The national registry BG-Pace includes systematic clinical, demographical, and procedural data for CIED implantations in Bulgaria. There is a growth in the implantation rates compared to previous periods, but they remain lower than the average number for Europe.

HTML

PDF

DOI: 10.3897/bgcardio.29.e108927

Authors: D. Marchov, M. Marinov, D. Boychev, E. Martinov, P. Kamenov, V. Gelev, V. Traykov

Abstract: Introduction: Catheter ablation (CA) is an established therapy for most arrhythmias. Non-fl uoroscopic three-dimensional (3D) electroanatomic mapping systems allow ablation of supraventricular tachycardia (SVT) and atrial fl utter (AFL) with zero or near-zero fl uoroscopy (ZF/NZF). The current study aims to report our initial experience with ZF/NZF in SVT or AFL CA. Material and methods: We conducted a single-center prospective registry enrolling consecutive patients referred for CA of SVT or AFL. ZF/NZF CA was attempted in all patients using a commercially available 3D mapping system. Fluoroscopy use was allowed at any point of the procedure. Procedural characteristics and long-term outcome were analyzed. The learning curve effect was also studied. Results: Sixty-three patients (age 53.5 ± 14.1, 57% males) with SVT or AFL were enrolled. According to arrhythmia type typical AVNRT was diagnosed in 36 (57.1%) cases, right atrial fl utter in 25 (39.7%) cases, left-sided accessory pathway in 1 (1.6%) and focal right atrial tachycardia in 1 (1.6%) case. Three patients (4.8%) had two arrhythmia substrates. The procedure was performed with ZF in 49/63 cases (77.8%), while NZF was necessary in 14 (22.2%) patients with a fl uoroscopy time of 220 ± 169 sec and a dose-area product of 7556 ± 5886 mGy*cm2. Median procedural time was 88 (IQR 25-75 percentile 71.5-116) min with 22 (IQR 25-75 percentile 16-31) min of mapping time. Acute procedural success was accomplished in all patients with no periprocedural complications. Over a follow-up of 12 ± 3 months, all patients remained arrhythmia-free. There was a learning curve effect with a signifi cant reduction of procedural time (P = 0.025) and a signifi cant difference (P = 0.019) in the rate of fl uoroscopy use among different periods of the study duration. Conclusion: ZF/NZF CA of SVT and AFL is associated with high effi cacy and safety. Entirely fl uoroless CA can be performed in the vast majority of patients. It is a feasible approach associated with a detectable learning curve effect.

HTML

XML

PDF

DOI: 10.3897/bgcardio.29.e115282

Authors: K. Dzhinsov

Abstract:

HTML

PDF

DOI: 10.3897/bgcardio.29.e117816

Authors: Vassil Traykov, Tchavdar Shalganov

Abstract:

HTML

PDF

DOI: 10.3897/bgcardio.29.e104528

Authors: T. Shalganov, M. Stoyanov, V. Traykov

Abstract: This study presents data from the national electronic registry BG-EPHY on electrophysiologic (EP) cardiac ablations in 2022. Material and methods: This is a retrospective study of a full one-year sample of the BG-EPHY registry. Sex and age distribution of the patients, number of ablations, use of electroanatomic mapping (EAM), irrigated and cryoablations, distribution of different types of arrhythmias, acute procedural success and complications are presented. Results: In 2022 seven EP centers performed 1369 ablations in 872 men (63.7%) and 497 women (57% increase compared to previous year), incl. 15 ablations in pediatric patients (1.1%). EAM was used in 746 procedures (54.5%), irrigated-tip catheter – in 814 (59.5%), cryoballoon catheter – in 130 (9.5%), and intracardiac echocardiography – in 33 (2.4%). The most frequently performed ablation was pulmonary vein isolation (40.2%), followed by ablation for AV nodal reentrant tachycardia (18.6%) and typical atrial fl utter (16.6%). The acute success was over 98%, while intraprocedural complications were less than 2%. Conclusion: The national registry of electrophysiology collects systematically and continuously basic data on all ablations of cardiac arrhythmias performed in the country. In 2022, during a subsiding COVID-19 pandemic and with the inclusion of new centers the number of ablations increased compared to 2021. Distribution of EP procedure types was similar to previous years. Acute success was very high, while intraprocedural complications were rare.

HTML

XML

PDF

DOI: 10.3897/bgcardio.29.e101578

Authors: M. Stoyanov, T. Shalganov

Abstract: Ventricular arrhythmias are among the most serious complications of myocardial infarction that defi ne not only increased morbidity and mortality, but also signifi cantly impaired quality of life. The pathogenesis of ventricular arrhythmias that arise during and after myocardial infarction is a combination of various triggering and modulating factors. We present a summary of the main structural and functional changes that occur with myocardial ischemia and create substrate for ventricular arrhythmias. The electrophysiological mechanisms underlying infarction-related ventricular arrhythmias are reviewed, as well as the most common pharmacological and non-pharmacological treatment’s strategies.

HTML

XML

PDF

DOI: 10.3897/bgcardio.28.e82407

Authors: T. Shalganov, M. Stoyanov, V. Traykov

Abstract: This study presents data from the national electronic registry BG-EPHY on electrophysiologic (EP) cardiac ablations in 2021. Material and methods: This is a retrospective study of a full one-year sample of the BG-EPHY registry. Sex and age distribution of the patients, number of ablations, electroanatomic mapping (EAM), irrigated and cryoablations, distribution of different types of arrhythmias, acute procedural success and complications are presented. Results: In 2021 fi ve EP centers performed 872 ablations in 546 men (62.6%) and 326 women (4.4% increase compared to previous year), incl. 6 ablations in pediatric patients (0.7%). EAM was used in 60.9% of the procedures, irrigation catheter was used in 55.2%, cryoballoon catheter – in 6%, and intracardiac echocardiography – in 4.2%. The most common ablation was pulmonary vein isolation, followed by ablation for AV nodal reentrant tachycardia and typical atrial fl utter. The acute success was over 98%, while intraprocedural complications were less than 2%. Conclusion: The national registry of electrophysiology collects systematically and continuously basic data on all ablations of cardiac arrhythmias performed in the country. In 2021, during a continuing COVID-19 pandemic the number of ablations increased slightly compared to the previous year. Distribution of EP procedure types was similar to previous years. Acute success was very high, while intraprocedural complications were rare.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e71009

Authors: Vassil Traykov, Tchavdar Shalganov, Lyubomir Dimitrov, Anna Kaneva, Stojan Lazarov, Dobri Dobrev, Valeri Gelev

Abstract: We present the case of a 23-year-old male diagnosed with a complex congenital heart disease (with single ventricle physiology) which necessitated many surgical interventions including total cavopulmonary connection. The patient presents with recurrent (almost daily) highly symptomatic atrial tachycardia with rapid ventricular rate and poor haemodynamic tolerance. Due to failure of antiarrhythmic drug therapy the patient was referred for catheter ablation. Atrial access was provided following transconduit puncture with a standard transseptal set. Crossing to the atrium with the transseptal introducer was not successful due to resistance from the conduit and the atrial wall. Therefore, balloon dilation of the puncture using a cutting balloon was carried out which resulted in easy crossing to the atrium with a steerable transseptal introducer. Several atrial tachyarrhythmias were induced two of which allowed mapping demonstrating a macroreentrant tachycardia dependent on the cavoannular isthmus as well as a complex figure-of-eight circuit involving right pulmonary veins and the right atrial appendage. Linear lesions transecting the critical isthmuses of the two circuits were delivered which rendered the patient noninducible. During a 9-month follow-up period the patient remained arrhythmia free.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e75847

Authors: Tchavdar Shalganov

Abstract: Editorial

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e72195

Authors: Nikolay Stoyanov, Dinko Kamburov, Nikolay Bonev, Mihail Protich, Vasil Velchev

Abstract: There has been increased rate of cardiac implantable electronic devices (CIED) implanted worldwide. Respectively the numbers of patients with absolute indications for lead extraction (pacemaker and ICD) grow up exponentially. The aim of our study is to present the initial experience and long-term results of pacemaker and ICD lead extraction in patients treated in Cardiology department of University hospital “Sveta Anna” Sofi a. Material and Methods: Retrospective study was performed of patients with CIED implanted greater than 1 year and indications for lead extraction. Clinical and procedural characteristics, success rate, complications rate, and reinfection rate data were collected and analyzed. Results: In the period August 2016 to May 2021, a total of 54 patients were admitted to our department with an absolute indication for lead extraction. A total of 114 pacemakers and ICD electrodes were extracted during 54 procedures. In 47 patients (87%) was shown complete technical success with removal of all hardware and in 53 patients (98.1%) clinical success of the procedure was found. The incidence of major periprocedural complications requiring urgent cardiac surgery in our series was 2 (3.7%). Follow-up revealed a very low recurrence infection rate – only 1 patient (1.9%). Conclusion: Lead extraction is a safe and effective procedure. The establishment of a specialized center with an organized system for lead extraction is key in achieving excellent short- and long-term results.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e72412

Authors: Mohamed Dardari, Alexandrina Nastasa, Corneliu Iorgulescu, Stefan Bogdan, Vlad Bataila, Radu Vatasescu

Abstract: Objective. Radiofrequency catheter ablation is an effective treatment option for cardiac arrhythmias including complex and ventricular arrhythmias. Remote magnetic catheter navigation (RMN) has been developed as a novel way of approach aiming to improve outcome and reduce complication rate, and reduce radiation exposure for both operator and patient. Our aim was to compare success and complication rate in patients with or without severely reduced left ventricular ejection fraction (LVEF). Methods. We retrospectively analyzed all the patients (n = 98) which have undergone RMN in our center between 2015-2021. No selection criteria for RMN procedure have been applied. All clinical and paraclinical, as well as procedural data were collected. Patients were divided into two groups, with or without severely reduced LVEF ≤ 35%. CARTO system was used for 3D electroanatomic mapping. RMN was done using Niobe ES system and an open-irrigated magnetic ablation catheter. Success rate was defi ned by complete elimination of clinical arrhythmia. Non-inducibility following ablation was assessed in all patients presenting with any type of ventricular arrhythmia other than premature ventricular contractions. Testing for inducibility was done by ventricular programmed pacing with up to four extra-stimuli. The statistical analysis was performed using SPSS software. P-value < 0.05 was considered signifi cant. Results. Successful ablation with complete elimination of the clinical arrhythmia was achieved in 92.3% of the patients with severely reduced LVEF and in 88.1% of patients with LVEF > 35% (p = 0.73). Overall minor complication rate was 2.04% with spontaneous resolution. No major complications were reported. Non-inducibility was achieved in 56.4% of the patients with LVEF ≤ 35% and in 79.2% of the patients with LVEF >35% (p = 0.023). Conclusion. Radiofrequency catheter ablation using RMN is effective and safe regardless of the presence or not of a severely reduced LVEF.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e71365

Authors: Boyan Kunev, Bilyana Bogdanova, Pero Popeski, Tchavdar Shalganov

Abstract: Atrial fi brillation (AF) is the most common arrhythmia in adults and requires permanent anticoagulation in the presence of risk factors. Left atrial (LA) thrombus is found in a signifi cant minority of patients despite anticoagulant treatment. We aimed to estimate the prevalence of LA thrombosis on uninterrupted oral anticoagulation (OAC) in AF patients and to determine associated demographic, clinical, echocardiographic and tomographic parameters. Material and methods: We present retrospective study of 702 hospitalizations in 582 patients (397 males, 68.2%) with AF and/or atrial fl utter on uninterrupted OAC for at least 3 weeks, assessed for LA thrombosis with transoesophageal echocardiography and/or cardiac computed tomography. Probability value of p ‹ 0.05 was considered signifi cant for all statistical analyses. Results: The prevalence of LA thrombosis was 6.2%, without signifi cant difference between patients on direct OAC (DOAC) or acenocoumarol (VKA). Non-paroxysmal arrhythmia was signifi cantly associated with LA thrombus, OR 0.369, 95% CI 0.159-0.857, p = 0.02. The proportion of patients on VKA with subtherapeutic INR was signifi cantly higher (30.7%), than the proportion of patients receiving too low dose of DOAC (9.7%), OR 4.1, 95%, CI 2 CI 2.7-6.23, р ‹ 0.001. No association was found between the LA appendage morphology type and the presence of LA thrombus. During a median follow-up of 30 days new stroke/transitory ischemic attack (TIA)/systemic embolism (SE) was registered in seven patients (1.34%), none of them with LA thrombus. Conclusion: The prevalence of LA thrombosis in the studied cohort is comparable to the published data and seemingly had no association with the OAC type. The incidence of stroke/TIA/SE was low on uninterrupted oral anticoagulation during short-term follow-up and there was no association between the presence of LA thrombus and thromboembolic event on follow-up. 

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e71177

Authors: Vassil Traykov, Svetoslav Iovev, Borislav Borisov, Ivaylo Kozhuharov, Momchil Marinov, Vasil Velchev

Abstract: The current study analyses the activity in cardiac pacing in Bulgaria in 2019, 2020 and 2021 based on data derived from a national registry of patients with cardiac electronic implantable devices (CIEDs). Materials and methods. Data from the national registry BG-Pace in the period 08.2019-06.2021 was retrospectively studied. Demographic data, procedure and device type, pacing mode, etiology, symptoms, preimplantation ECG, number of implantations and centre and operator volumes were analysed. Results. Six thousand nine hundred forty-nine devices were implanted by 47 operators in 28 centres for the study period. Median age was 75 (IQR 68-81, 21-103) years in males and 77 (IQR 71-82, 17-98) years in females, P ‹ 0.05. The largest number of devices were implanted in the age group 70-79 years. The most commonly implanted CIEDs were antibradycardia devices with a total of 486.7/million implantations for the period 08.2019-08.2020 and 353.9/million for the period 08.2020-06.2021. Implanted cardioverter-defibrillators demonstrated a growth from 14.1/million to 20.1/million in the period 08.2020 – 06.2021. The number of all implantations dropped signifi cantly during the two epidemic waves of COVID-19. The mean number of implantations per centre and per operator for the whole period was 232.3±204 (2-705) and 148±139.1 (2-660), respectively. Dual chamber device implantations were more prevalent, representing 65.8% of implantations in AV block I and II degree, 63.5% in complete AV block, 59.8% in intraventricular conduction disturbances and 60.9% in sick sinus syndrome. Pacing modes with atrial sensing represented more than 55% of the implantations for all indications. Increasing age was associated with signifi cantly more common use of VVI pacing mode (P ‹ 0.001). Conclusion. The national registry BG-Pace includes systematic clinical, demographical and procedural data for CIED implantations in Bulgaria. Results demonstrate lower number of implantations compared to the average European volume. There was a signifi cant drop in the implantation rate during the two waves of COVID-19. 

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e71311

Authors: Svetla Dineva, Milko Stoyanov, Aneliya Partenova, Boyan Kunev, Victoria Stoyanova, Tchavdar Shalganov

Abstract: Anatomical variants of pulmonary venous drainage in the left atrium are often found. Divergent results have been reported on the impact of variant anatomy on atrial fi brillation (AF) recurrence after catheter ablation. We aimed to study the frequency of different anatomical variants of pulmonary venous drainage and their relationship with documented recurrences of AF after ablation. Material and methods: A retrospective study of patients with AF in whom radiofrequency pulmonary vein isolation was done after previously performed cardiac contrast-enhanced multidetector computed tomography. Clinical and procedural characteristics, type and frequency of anatomical variants of the veno-atrial junction and their association with AF recurrences were studied. Results: One hundred seventy-seven patients (112 men, 63.3%) with AF were studied, of which 148 (83.6%) with paroxysmal AF. Variant anatomy was found in 91 patients (51.4%). In 20.9% there was a common left trunk, in 23.2% – more or less than two right-sided veins, and in 7.3% – variations for both right and left veins. No differences in clinical and procedural characteristics were found between the groups with normal and variant anatomy. Recurrences of AF and their association with pulmonary venous anatomy were studied in 104 patients with follow-up ≥ 3 months. No signifi cant relation was found between the presence of variant anatomy and AF recurrences within the blinding period after ablation, OR = 0.864, 95% CI = 0.397 – 1.88, p = 0.843, nor afterwards, OR = 1.12, 95% CI = 0.5 – 2.5, p = 0.839. Cox regression analysis showed no differences in AF recurrence-free survival regardless of the anatomical variant of pulmonary venous drainage, HR = 1.09, 95% CI = 0.58 – 2.05, p = 0.779. Conclusion: In this local population of patients with AF, the incidence of variant pulmonary venous drainage is just over 50%. No association was found between variant anatomy and the rate of AF recurrences after fi rst pulmonary vein isolation.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e68838

Authors: Tchavdar Shalganov, Milko Stoyanov

Abstract: The catheter ablation of cardiac arrhythmias causes myocardial destruction and increase of the cardiac troponin and C-reactive protein (CRP). Data regarding dynamics of high-sensitivity troponin during irrigated ablation are scarce, and for diagnostic electrophysiological studies (EPS) are lacking. We aimed to study the periprocedural dynamics of high-sensitivity cardiac troponin I (hscTn I) and CRP, as well as their relation to different procedural parameters during EPS and ablation of various arrhythmias. Material and methods: Consecutive patients with EPS or ablation performed were studied prospectively. Clinical and procedural characteristics, and pre- and postprocedural values of hscTn I and CRP are presented at days 1, 2 and 3. Six indices were chosen as procedural markers of induced myocardial injury. P-value < 0.05 was accepted as statistically signifi cant for all tests performed. Results: Eight EPS and 98 ablations were performed in 103 patients (58 males, 56.3%). For ablations the baseline values of hscTn I at day 1 were 3.2 ng/L (1.7-4.93), while postprocedural values at days 2 and 3 were 500 ng/L (269-1044) and 404 ng/L (179-1017), р < 0.05 for all days. Postprocedural hscTn I values were moderately to strongly correlated to radiofrequency (RF) energy, time and number of RF applications. Postprocedural increase of CRP was also significant, but its magnitude was much smaller. Its correlation to procedural indices was weak. For EPS the baseline values of hscTn I were 5.95 ± 5.34 ng/L (0.6-15.9), while for the next 2 days these were 53.2 ± 43.1 ng/L (13.3-144) и 16.7 ± 9.65 ng/L (3.3-30.9), р < 0.05 for all days. Conclusion: Signifi cant postprocedural increase of hscTn I was detected in all electrophysiology procedures – EPS and ablations. This increase was more pronounced and prolonged to at least the next day after ablation. It was clearly correlated to the cumulative RF energy, RF time and number of RF applications. Early increase of CRP was also signifi cant, but to a lesser magnitude and in weak correlation to the procedural parameters.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e66077

Authors: Tchavdar Shalganov, Milko Stoyanov, Vassil Traykov

Abstract: This study presents data from the national electronic registry BG-EPHY on electrophysiologic (EP) cardiac ablations in 2019 and 2020. Material and methods. This is a retrospective study of a full two-year sample of the BG-EPHY registry. Sex and age distribution of the patients, number of ablations, electroanatomic mapping (EAM), irrigated ablations, distribution of different types of arrhythmia, intraprocedural success and complications are presented. Results. In 2019 four EP laboratories performed 1033 ablations in 652 men (63.1%) and 381 women, incl. 12 pediatric ablations (1.2%). EAM was used in 46.7% of the procedures, irrigation catheter was used in 52.2%, and cryocatheter – in 0.5%. The most common procedure was pulmonary vein isolation, followed by ablation for AV nodal reentrant tachycardia and typical atrial flutter. In 2020 five EP laboratories performed 835 ablations in 508 men (60.8%) and 327 women, incl. 8 pediatric ablations (1%). EAM was used in 50.9% of the ablations, irrigation catheter – in 54.5%, and cryocatheter – in 3.8%. The most common procedure was again pulmonary vein isolation. Ablation of typical atrial flutter was the second most frequently performed procedure, ahead of AV nodal reentrant tachycardia. In 2020 the number of ablations of accessory pathways also distinctly dropped by 37%. In both years the acute success was over 98%, and the complications were less than 2%. Conclusion. The national registry of electrophysiology collects systematically and continuously basic data on all cardiac ablations performed in the country. The structure of the EP service is remarkably similar to other European countries. Acute success is very high, while intraprocedural complications are rare. In 2020 the number of the ablations dropped by 19% as a consequence of the COVID-19 pandemic.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e67571

Authors: Damyan Boychev, Naidenka Zlatareva, Ivo Petrov

Abstract: The coronavirus disease 2019 (COVID-19) pandemic has affected health and economies around the globe at an unprecedented scale. Since the fi rst registered case of Covid-19 in December of 2019 until May 2021, more than 167 mil people have been infected and more than 3.5 mil have died. Patients with cardiovascular disease are one of the most affected groups. First, because cardiovascular disease, for example, stable angina or past myocardial infarction, weakens system’s abilities of dealing with stress due to infl ammation. Secondly, because COVID-19 is associated with multiple different mechanisms of cardiovascular injury. Developing COVID-19 related cardiovascular complications is associated with increased morbidity and mortality. The goal of this review is to present the known up to this moment mechanisms of cardiovascular injury and complications after COVID-19.

HTML

XML

PDF

DOI: 10.3897/bgcardio.27.e64765

Authors: Vassil Traykov, Valeri Gelev

Abstract: Coronavirus pandemic has led to the accumulation of substantial evidence about the arrhythmogenic potential of COVID-19. Arrhythmias in COVID-19 develop more frequently in severely and critically ill patients. Hypoxia, direct or indirect myocardial injury as well as the role of immune response to the virus are among the possible mechanisms of arrhythmia. Although management of these arrhythmias during the pandemic does not differ signifi cantly from the currently accepted standard of care, the potential for drug interactions and the impact of some antiviral medications on the QTc interval should be taken into consideration. The current review aims to summarize the available evidence and provide practical guidance on the management of arrhythmia patients with COVID-19.

HTML

XML

PDF

DOI: 10.3897/bgcardio.26.e59263

Authors: Tchavdar Shalganov, Milko Stoyanov, Metodi Mirazchiyski, Boyan Kunev

Abstract: The presence of left atrial (LA) dilation, as well as the presence and extent of LA zones with abnormal myocardial voltage are among the factors for recurrence of atrial fibrillation (AF) after pulmonary vein isolation (PVI). Our aim was to study the rate of recurrences after first ablation for AF in patients with and without LA dilation or abnormal myocardial voltage at follow-up. Material and Methods. This is a retrospective study of patients with paroxysmal AF and first PVI preceded by high density voltage mapping in sinus rhythm. Clinical and procedural characteristics, recurrence-free survival and predictors for recurrence were studied. P value < 0.05 was considered significant. Results. Sixty-three patients (65% males) were studied. Mean follow- up duration was 12 months beyond the end of the 3-month blinding period. Recurrence-free survival at 12 months was 74.8% and varied widely with the presence of LA dilation or early recurrences within the blinding period. In patients with non-dilated LA arrhythmia-free survival was 82% vs. 66% in those with LA dilation, HR = 2.61, 95% CI 1.06-6.41, logrank p = 0.07. Patients without early recurrence had 12-month recurrence-free survival of 83.8% vs. 52% in those with early recurrence, HR 4.17, 95% CI 1.48-11.76, logrank p = 0.001. The presence and area of abnormal voltage zones were not different in patients with and without recurrence. Conclusion. The rate of AF recurrences after PVI at 15 months after the procedure was 25%, but it depended highly on the early recurrences during the blinding period and the degree of LA dilation.

HTML

XML

PDF

DOI: 10.3897/bgcardio.26.e56371

Authors: Tchavdar Shalganov, Milko Stoyanov, Metodi Mirazchiyski, Boyan Kunev

Abstract: There is paucity of studies correlating the left atrial (LA) dilation and the LA total and abnormal voltage areas in patients with atrial fi brillation (AF). We sought to determine the area of LA and its segments by high-density mapping in patients with paroxysmal AF, and to correlate the LA dilation defi ned by echocardiography with the total and the abnormal LA areas. Material and Methods. Retrospective study of patients with paroxysmal AF and pulmonary vein isolation proceeded by high-density mapping in sinus rhythm. All had transthoracic echocardiography and LA dilation, if present, was graded as mild/moderate-severe. LA voltage was defi ned as low (< 0.5 mV) or scar (< 0.1 mV). The LA was divided in 5 segments and the total and segmental area, low voltage area and scar area were measured. Data were presented as mean ± SD or median and interquartile interval (25-75%) depending on normality of distribution. Shapiro-Wilk test, Spearman T correlation, Kruskal-Wallis, and ANOVA analysis were used. A p-value < 0.05 was considered significant. Results.  Sixty-seven patients (66% males) were studied. LA enlargement was present in 58% (mild enlargement in 39%, moderate/severe in 19%). Low voltage and scar areas were found in both groups with and without LA dilation. Moderate correlation was found between the percentage of abnormal area and the degree of LA dilation (none vs mild vs moderate/severe), rho = 0.44, p = 0.0002. In patients with non-dilated LA the mean total LA area was 100.4 ± 17 cm2 and the abnormal area was < 10% (9.9%, 6.2-14.8%), with barely detectable scar. In patients with LA enlargement the total area was approximately 10% larger (109.8 cm2, 100.9-123.8 cm2), however the abnormal area was almost doubled (17.1%, 11.1-26.8%), and there were small yet measurable dense scar areas. Conclusions. Low voltage LA areas < 0.5 mV were found universally by high-density mapping in patients with paroxysmal AF, irrespective of the presence of LA enlargement. However, only patients with LA enlargement had measurable scar areas. The total abnormal area correlated moderately with the degree of LA dilation defi ned by echocardiography.

HTML

XML

PDF

DOI: 10.3897/bgcardio.26.e52960

Authors: Iskren Garvanski, Ivo Petrov, Iana Simova

Abstract: With the rising incidence and wider spread of the COVID-19 pandemic worldwide, it is of great importance to safely use potentially effective medicines to treat the infection. In recent weeks, a number of publications have emerged describing the likely effect of the use of known drugs, including chloroquine and hydroxychloroquine, and their combination with azithromycin. One of the most serious risks associated with the use of these medications is the drug-induced QT prolongation, which in turn increases the risk of developing torsades de pointes (TdP) and sudden cardiac death (SCD). In this document, we describe an approach to screen patients and monitor them with the aim to reduce the risk of drug-induced side effects.

HTML

XML

PDF

DOI: 10.3897/bgcardio.25.e51729

Authors: Tchavdar Shalganov, Milko Stoyanov

Abstract: A female patient with nonautomatic focal atrial tachycardia with paraHissian location of the focus and previously unsuccessful ablation attempt in the right atrium (RA) is presented. Electroanatomic mapping demonstrated sequential activation of the anteroseptal area of the RA, anteroseptal area of the left atrium and non-coronary sinus of Valsalva with minimal differences in local activation times. Because of perceived risk of conduction disturbances ablation was done in the non-coronary sinus with immediate termination of the tachycardia, subsequent non-inducibility and without any complications.

HTML

XML

PDF

DOI: 10.3897/bgcardio.26.e53773

Authors: Monika Kozieł, Gregory Y. H. Lip, Tatjana S. Potpara

Abstract: Real world registries of patients with atrial fi brillation (AF) have provided important evidence on contemporary AF management and adherence to guidelines in real-world patients across most of regions in Europe. While prospective randomized clinical trials are the ‘gold standard’ of evidence, we recognize that trials have specifi c inclusion/exclusion criteria and many groups of patients can be under-represented. Thus, real world evidence is needed to supplement and augment the evidence, especially for the under-represented patient groups (eg. the very elderly and frail, ethnic minorities, end stage renal failure, those in nursing homes, cognitive impairment, etc) that have been largely under-represented or excluded from clinical trials. The BALKAN-AF survey is the largest prospective, multicenter (a total of 49 centres), observational AF dataset from the Balkans, a European region inhabited by about 10% of the European population that has been under-represented in many prior clinical trials or registries. In BALKAN-AF, data regarding consecutive subjects with electrocardiographically documented non-valvular AF were collected in seven Balkan countries (Albania, Bosnia & Herzegovina, Bulgaria, Croatia, Montenegro, Romania and Serbia) by a cardiologist or an internal medicine specialist where cardiologist was not available. The Serbian Atrial Fibrillation Association created and conducted the BALKAN-AF survey (performed from December 2014 to February 2015).

HTML

XML

PDF